Ruggero M. De Maria
Member of Scientific Advisory BoardProfessor Ruggero M. De Maria, Ph.D. & M.D. serves on the Scientific Advisory Board of HiberCell, Inc. Professor De Maria serves as Member of Scientific Advisory Board at Kiromic BioPharma, Inc. Professor De Maria has been Member of Scientific Advisory Board at National Foundation For Cancer Research since October 2015. He is Scientific Director of Regina Elena National Cancer Institute (Rome, Italy) where he was appointed by the Italian Minister of Health to manage the scientific activities between basic, translational and clinical researchers. His leadership consists in increasing scientific productivity among clinicians and basic scientists. His research is centered on the molecular characterization of cancer stem cells with the aim of discovering innovative biomarkers and molecular targets to improve cancer management and develop novel cancer therapies. He was Head of the Department of Hematology, Oncology and Molecular Medicine at the National Institute of Health, Rome, his research team was the first to isolate CSCs from colon and lung cancers and develop innovative CSC-based preclinical models. Other research interests comprise the study of micro RNA and the micro environment in solid tumors. Moreover, he has published several seminal articles on glioblastoma stem cells. Professor De Maria was the President of the Italian ACC Association (Alleanza Contro il Cancro/Alliance in the fight against Cancer) in 2013; he serves as a Member of the Pezcoller Foundation-AACR Innovator Scientific Advisory Board.
Positions
- Company NameKiromic BioPharma, Inc.Stock CodeKRBPQPositionMember of Scientific Advisory Board
